Dustin Shilling

1.1k total citations
15 papers, 501 citations indexed

About

Dustin Shilling is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Dustin Shilling has authored 15 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Dustin Shilling's work include Viral-associated cancers and disorders (7 papers), Histiocytic Disorders and Treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Dustin Shilling is often cited by papers focused on Viral-associated cancers and disorders (7 papers), Histiocytic Disorders and Treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Dustin Shilling collaborates with scholars based in United States, Canada and Japan. Dustin Shilling's co-authors include David C. Fajgenbaum, J. Kevin Foskett, Don‐On Daniel Mak, David E. Kang, Ted Abel, Marioly Müller, Hajime Takano, Douglas A. Coulter, B.L. Tempel and Frits van Rhee and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Blood.

In The Last Decade

Dustin Shilling

15 papers receiving 493 citations

Peers

Countries citing papers authored by Dustin Shilling

Since Specialization

Citations

This map shows the geographic impact of Dustin Shilling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dustin Shilling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dustin Shilling more than expected).

Fields of papers citing papers by Dustin Shilling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dustin Shilling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dustin Shilling. The network helps show where Dustin Shilling may publish in the future.

Co-authorship network of co-authors of Dustin Shilling

This figure shows the co-authorship network connecting the top 25 collaborators of Dustin Shilling. A scholar is included among the top collaborators of Dustin Shilling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dustin Shilling. Dustin Shilling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease 2019 ·PLoS ONE ·Christopher S. Nabel, Stephen Sameroff, Dustin Shilling, Daisy Alapat, Jason R. Ruth, Mitsuhiro Kawano, Yasuharu Sato, Katie Stone, Signe Spetalen, Federico Valdivieso, Michael D. Feldman, Amy Chadburn, Alexander Fosså, Frits van Rhee, W. Ian Lipkin, David C. Fajgenbaum	27
2	The Collaborative Network Approach: a model for advancing patient-centric research for Castleman disease and other rare diseases 2019 ·Emerging Topics in Life Sciences ·(unknown), Dustin Shilling, David C. Fajgenbaum	3
3	Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease 2018 ·American Journal of Hematology ·Sheila K. Pierson, Aaron J. Stonestrom, Dustin Shilling, Jason R. Ruth, Christopher S. Nabel, Amrit Singh, Yue Ren, Katie Stone, Hongzhe Li, Frits van Rhee, David C. Fajgenbaum	60
4	Predictors of response to anti‐IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data 2018 ·British Journal of Haematology ·(unknown), Sheila K. Pierson, Dustin Shilling, (unknown), (unknown), Mary Guilfoyle, Craig Tendler, Frits van Rhee, David C. Fajgenbaum	36
5	Oligoclonal Expansion of Cd8+ T Cells during Idiopathic Multicentric Castleman Disease Flares Suggests an Antigen Driven Process 2018 ·Blood ·Dustin Shilling, Jason Stadanlick, Wenzhao Meng, Abhishek Rao, Vera P. Krymskaya, Eline T. Luning Prak, Evgeniy Eruslanov, David C. Fajgenbaum	1
6	Single-Cell RNA-Sequencing of Peripheral Blood Mononuclear Cells Reveals Changes in Immune Cell Composition and Distinct Inflammatory Gene Expression Profiles during Idiopathic Multicentric Castleman Disease Flare 2018 ·Blood ·(unknown), Dustin Shilling, Michael V. Gonzalez, Charlly Kao, Håkon Håkonarson, Taku Kambayashi, David C. Fajgenbaum	2
7	Castleman Disease Pathogenesis 2017 ·Hematology/Oncology Clinics of North America ·David C. Fajgenbaum, Dustin Shilling	61
8	Resistance to Noise-Induced Hearing Loss in 129S6 and MOLF Mice: Identification of Independent, Overlapping, and Interacting Chromosomal Regions 2014 ·Journal of the Association for Research in Otolaryngology ·Valerie A. Street, Sharon G. Kujawa, Ani Manichaikul, Karl W. Broman, (unknown), Dustin Shilling, Ayaka J. Iwata, Linda C. Robinson, Carol A. Robbins, Jin Li, M. Charles Liberman, Bruce L. Tempel	10
9	Suppression of InsP₃Receptor-Mediated Ca²⁺Signaling Alleviates Mutant Presenilin-Linked Familial Alzheimer's Disease Pathogenesis 2014 ·Journal of Neuroscience ·Dustin Shilling, Marioly Müller, Hajime Takano, Don‐On Daniel Mak, Ted Abel, Douglas A. Coulter, J. Kevin Foskett	94
10	A Host GPCR Signaling Network Required for the Cytolysis of Infected Cells Facilitates Release of Apicomplexan Parasites 2013 ·Cell Host & Microbe ·(unknown), Satish Mishra, Christopher D. Dupont, Melissa S. Love, Bhumit A. Patel, Dustin Shilling, Marcelo G. Kazanietz, J. Kevin Foskett, Christopher A. Hunter, Photini Sinnis, Doron C. Greenbaum	31
11	Lack of Evidence for Presenilins as Endoplasmic Reticulum Ca2+ Leak Channels 2012 ·Journal of Biological Chemistry ·Dustin Shilling, Don‐On Daniel Mak, David E. Kang, J. Kevin Foskett	82
12	Reply to Bezprozvanny et al.: Response to Shilling et al. (10.1074/jbc.M111.300491) 2012 ·Journal of Biological Chemistry ·Dustin Shilling, J. Kevin Foskett	2
13	The plasma membrane calcium ATPase and disease 2007 ·Sub-cellular biochemistry ·B.L. Tempel, Dustin Shilling	23
14	3p− syndrome defines a hearing loss locus in 3p25.3 2007 ·Hearing Research ·Brendan J. McCullough, Joe C. Adams, Dustin Shilling, M. Patrick Feeney, Kathleen C.Y. Sie, Bruce L. Tempel	19
15	Sphingosine 1-Phosphate Receptor 2 Negatively Regulates Neointimal Formation in Mouse Arteries 2007 ·Circulation Research ·Takuya Shimizu, Tatsu Nakazawa, (unknown), Frank Dastvan, Dustin Shilling, Günter Daum, M A Reidy	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact